Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients. - Wikidata - wikimedia - TriplyDB

Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients.

Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients.

http://www.wikidata.org/entity/Q34176387

about

At the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis Chemoprevention in patients with genetic risk of colorectal cancers Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer Perspective: Chemoprevention of colorectal neoplasia: Translating scientific promise into clinical practice Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase.DFMO: targeted risk reduction therapy for colorectal neoplasia.Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention.Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.Dietary polyamine intake and risk of colorectal adenomatous polyps Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas.Meat consumption, ornithine decarboxylase gene polymorphism, and outcomes after colorectal cancer diagnosis.Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas.Lack of evidence for the association of ornithine decarboxylase (+316 G>A), spermidine/spermine acetyl transferase (-1415 T>C) gene polymorphisms with calcium oxalate stone disease.Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention.Aspirin and colorectal cancer: the promise of precision chemoprevention.Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas.Polyamines and Cancer.

P2860

Q27023485-E7BFE7F9-B67D-4504-AB73-0619BB80383C Q28252395-290BE139-54B5-4160-B8E9-8A79C21E6D6F Q34170508-B84249B2-2CDB-4BBC-B980-666F0A46DC3C Q34296467-1CA4CEF2-F9FD-4B9A-910F-123CD3CACB14 Q35064951-065B621F-A919-422B-ACF7-097E6B1CD08C Q35133419-A673F44C-53B5-4A1A-89D8-16519EA80F07 Q35583635-029A95F7-85A8-4521-9C29-FD3C05F749CA Q35597150-6E574C9C-C737-44DF-9E7A-9BE4CDE6DD8B Q35619102-77DA21F6-7520-4AD6-A4EC-8070949757BC Q36030441-7F2458A4-8FA9-4075-AD80-BBE87D2842E5 Q36236838-F5711F3D-1569-4EF7-B8D9-4789D34A7369 Q36450416-3064C6A3-CCE7-46EC-ACDF-5E54B6E02988 Q36671933-E1131AD4-98A1-4E61-96AB-9C1B7537FF8A Q37567536-B44CDF84-8DFE-4D7D-BFB7-8D2AAFF28920 Q38114862-64FAFF5E-2E09-422D-96A8-3E984353109A Q38730064-A52A3E6B-5EF0-40FB-9FE0-DE357C99EAF5 Q50084342-45919C0D-3861-4E9E-82FF-3F13F8F639FE Q50100821-C3F4F922-E39D-4761-9083-2237179A878C

P2860

Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients.

http://www.wikidata.org/entity/Q34176387

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.

@ast

Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.

@en

Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.

@nl

type

label

Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.

@ast

Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.

@en

Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.

@nl

prefLabel

Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.

@ast

Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.

@en

Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.

@nl

P1433

Q34176387-B50F9358-2A22-46CF-A615-C02F6564DFF5

P1476

Q34176387-9E5C3B57-FDD6-4722-9450-AECF4EF7A960

P2093

Q34176387-281ECF6C-1330-477E-ACD0-2691E41C904A

Q34176387-3B839338-D0CF-4008-B99B-A262943FDFAB

Q34176387-5A053EE7-9881-4DB2-A92B-9023EB61B7B7

Q34176387-9980859A-A36F-408A-9231-7C06A7824AF0

Q34176387-B4D2F5DD-7776-419B-BF48-974A33D9661C

Q34176387-CB25B830-02D2-4670-906F-F12D1D1114E6

P2860

Q34176387-0B12FD2F-C5D3-47C2-80CC-9694AAAEB6E6

Q34176387-2C86D19A-1559-450A-A059-070E23EB7ADE

Q34176387-2E79FB83-5610-468B-8999-E22B63904D27

Q34176387-3C949D69-12C6-4FDE-A847-A7CD46CD3CF0

Q34176387-4439C1D8-C98E-489F-B37D-D6495BA3F672

Q34176387-5FEAA175-5B43-47E7-B7A3-DBF5E54B1B56

Q34176387-7577115E-5278-40C0-9741-77207574C3EB

Q34176387-8CE69A58-AEB2-4753-AE1F-EEA60A95A8EA

Q34176387-9C74A5D8-927F-4DCC-A44F-F171661D367F

Q34176387-A4E8D46B-36EC-4D5C-8B08-EC419445EAE7

P304

Q34176387-988827D5-49CA-4601-B849-9D9CDE4DFB3E

P31

Q34176387-3244A980-5450-44BA-AB99-233A7F6CACE4

P356

Q34176387-1A546098-FBBF-43B7-A21B-9D14D3768E83

P407

Q34176387-A0B5AAB1-7630-4B6E-9BD5-C6CA5B9CC185

P433

Q34176387-E78C8732-0944-4C01-A54F-0AEF9C6B7541

P478

Q34176387-974C60AD-DA97-462A-B35D-4E5282EB1BF4

P577

Q34176387-97CBC52F-64ED-4401-AB0D-394BD4C7F7FE

P5875

Q34176387-2441B8E8-C403-4FAB-A609-5A2165A432A5

P698

Q34176387-74C09642-CB6E-45A6-BD30-8C6356DC7CD0

P921

Q34176387-B5235903-2E69-4585-964A-6E9B3168C289

P932

Q34176387-6396E053-1730-4DFD-8A8C-FD67A90610E5

P356

P1433

Journal of the National Cancer Institute

P1476

Ornithine decarboxylase-1 poly ...... g colorectal adenoma patients.

@en

P2093

Christine E McLaren

http://www.w3.org/2001/XMLSchema#string

Eugene W Gerner

http://www.w3.org/2001/XMLSchema#string

Frank L Meyskens

http://www.w3.org/2001/XMLSchema#string

Jason A Zell

http://www.w3.org/2001/XMLSchema#string

Patricia A Thompson

http://www.w3.org/2001/XMLSchema#string

Wen-Pin Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene

Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention

Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas

Chemoprevention strategies using NSAIDs and COX-2 inhibitors.

Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.

Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival.

Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer.

Functional analysis of human ornithine decarboxylase alleles.

Longitudinal assessment of air conduction audiograms in a phase III clinical trial of difluoromethylornithine and sulindac for prevention of sporadic colorectal adenomas.

Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention.

P304

1513-1516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJQ325

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46009616

http://www.w3.org/2001/XMLSchema#string

P698

20798393

http://www.w3.org/2001/XMLSchema#string

P921

(RS)-eflornithine

P932

2950167

http://www.w3.org/2001/XMLSchema#string